denosumab
Form | Strength |
---|---|
SOLUTION, SUBCUTANEOUS | 60 mg/mL; 120 mg/1.7 mL |
Per policy, use of these medications is restricted as noted below: | |
---|---|
generic (Brand) | Restrictions |
denosumab (Prolia, Xgeva) | Restricted from being administered at IMH, including ICS. |